Prostate carcinoma: atrophy or not atrophy that is the question.

[1]  A. Sciarra,et al.  Inflammation and chronic prostatic diseases: evidence for a link? , 2007, European urology.

[2]  G. Bartsch,et al.  Gain of chromosome X in prostatic atrophy detected by CGH and FISH analyses , 2007, The Prostate.

[3]  Christian Kolbitsch,et al.  The association between local atherosclerosis and prostate cancer , 2007, BJU international.

[4]  Ximing J. Yang,et al.  A Working Group Classification of Focal Prostate Atrophy Lesions , 2006, The American journal of surgical pathology.

[5]  G. Bartsch,et al.  Assessment of aberrations on chromosome 8 in prostatic atrophy , 2006, BJU international.

[6]  T. H. van der Kwast,et al.  Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. , 2005, Urology.

[7]  J. Cigudosa,et al.  Immortalization of primary human prostate epithelial cells by c-Myc. , 2005, Cancer research.

[8]  A. Bergh,et al.  Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase‐2, Bcl‐2, and cell proliferation in the glandular epithelium , 2004, The Prostate.

[9]  D. Beach,et al.  Myc confers androgen-independent prostate cancer cell growth. , 2003, The Journal of clinical investigation.

[10]  J. Hicks,et al.  Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. , 2003, The American journal of pathology.

[11]  A. Billis,et al.  Inflammatory atrophy of the prostate. Prevalence and significance. , 2003, Archives of pathology & laboratory medicine.

[12]  W. Isaacs,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii , 2022 .

[13]  H. Mukhtar,et al.  Cyclooxygenase-2 and prostate carcinogenesis. , 2003, Cancer letters.

[14]  E. Bergstralh,et al.  Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ‐confined prostate cancer , 2002, Genes, chromosomes & cancer.

[15]  R. Shah,et al.  Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? , 2001, The American journal of pathology.

[16]  R L Vessella,et al.  Advances in Brief Amplification and Overexpression of Androgen Receptor Gene in Hormone-Refractory Prostate Cancer 1 , 2001 .

[17]  A. De Marzo,et al.  Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. , 2000, Urology.

[18]  T. Rebbeck,et al.  Association of HPC2/ELAC2 genotypes and prostate cancer. , 2000, American journal of human genetics.

[19]  J. Macoska,et al.  8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer. , 2000, Urology.

[20]  J. McNeal,et al.  Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: Significance for cancer progression , 2000, The Prostate.

[21]  J. Epstein,et al.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. , 1999, The American journal of pathology.

[22]  J. Epstein,et al.  Histology and cellular kinetics of prostatic atrophy. , 1998, The American journal of surgical pathology.

[23]  W. Grizzle,et al.  Expression of nm23-H1 in prostatic intraepithelial neoplasia and adenocarcinoma. , 1996, Human pathology.

[24]  R. Kirby,et al.  Ki-67 expression in early prostate cancer and associated pathological lesions. , 1996, Journal of clinical pathology.

[25]  R. Montironi,et al.  Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN). , 1993, Anticancer research.

[26]  P. Walsh,et al.  Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. , 1993, Cancer research.

[27]  D. Bostwick,et al.  Prostatic Intra‐Epithelial Neoplasia and Early Invasion in Prostate Cancer , 1987, Cancer.

[28]  L. M. Franks.  Atrophy and hyperplasia in the prostate proper. , 1954, The Journal of pathology and bacteriology.

[29]  B. Krušlin,et al.  Different types of atrophy in the prostate with and without adenocarcinoma. , 2007, European urology.

[30]  R. Montironi,et al.  Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia , 2005, Virchows Archiv A.

[31]  W. Timens.  Update in Pathology 2005. , 2005 .

[32]  Randall Harris,et al.  Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study. , 2000, Oncology reports.

[33]  A. Billis.  Prostatic atrophy: an autopsy study of a histologic mimic of adenocarcinoma. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[34]  D. Bostwick.  Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma. , 1996, European urology.